MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 22.20
-0.98 (-4.23%)
Oct 2, 2026, 5:35 PM CET
MedinCell Market Cap
MedinCell has a market cap or net worth of €797.24 million as of October 2, 2026. Its market cap has decreased by -3.56% in one year.
Market Cap
797.24M
Enterprise Value
784.33M
Revenue
24.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
€22.20
ChartMarket Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 797.24M, an increase of 445.66%. That is a compound annual growth rate of 23.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 797.24M | -4.43% |
| Dec 31, 2025 | 834.19M | 71.72% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 7.65B |
| Nanobiotix | 1.29B |
| Inventiva | 778.54M |
| DBV Technologies | 579.99M |
| Valneva SE | 495.17M |
| Genfit | 472.23M |
| Valerio Therapeutics Société anonyme | 265.21M |
| Transgene | 195.55M |